Hubei Jumpcan Pharmaceutical Co., Ltd Class ASSE: 600566

"Hubei Jumpcan Pharmaceutical Co., Ltd."Announcement on Obtaining Drug Registration Certificate by Subsidiary

Aug 10, 2026 · Issued by Hubei Jumpcan Pharmaceutical Co., Ltd Class A via Shanghai Stock Exchange

Announcement on Obtaining Drug Registration Certificate by Subsidiary

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

Earlier from Hubei Jumpcan Pharmaceutical Co., Ltd Class A

"Hubei Jumpcan Pharmaceutical Co., Ltd."Announcement on Implementation of Repurchase and Cancellation of Certain Restricted Shares under the 2022 Restricted Share and Stock Option Incentive PlanAug 8
"Hubei Jumpcan Pharmaceutical Co., Ltd."Announcement on the Shareholding Reduction Plan of Certain Directors and Senior ManagementAug 7
"Hubei Jumpcan Pharmaceutical Co., Ltd."Indicative Announcement on Restricted Exercise Period for the Initial Grant of Stock Options under the 2022 Restricted Share and Stock Option Incentive PlanAug 6
"Hubei Jumpcan Pharmaceutical Co., Ltd."Announcement on Progress in Repurchasing Shares through Call AuctionAug 1

All Hubei Jumpcan Pharmaceutical Co., Ltd Class A news releases